Oric Pharmaceuticals (ORIC) Treasury Shares (2019 - 2026)
Oric Pharmaceuticals' (ORIC) quarterly Treasury Shares came in at $1.1 million in Q1 2026, up 18.06% YoY from $920060.0 in Q1 2025, and up 86.46% on a QoQ basis from $582533.0 in Q4 2025.
Oric Pharmaceuticals (ORIC) Treasury Shares (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals (ORIC) has 7 years of Treasury Shares data on file, last reported at $1.1 million in Q1 2026.
- Quarterly Treasury Shares rose 18.06% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 18.06% YoY) and the FY2025 annual result came in at $582533.0, up 25.95% from the prior year.
- Treasury Shares advanced to $1.1 million in Q1 2026, from $582533.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $1.1 million in Q1 2026 to a low of $191925.0 in Q4 2022.
- A 5-year average of $571258.1 and a median of $485942.0 in 2023 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2023 — Treasury Shares soared 123.19% — and 2026, when it advanced 18.06%.
- Tracing ORIC's Treasury Shares over 5 years: stood at $191925.0 in 2022, then surged by 72.27% to $330631.0 in 2023, then soared by 39.89% to $462507.0 in 2024, then advanced by 25.95% to $582533.0 in 2025, then soared by 86.46% to $1.1 million in 2026.
- The last three Treasury Shares figures came in at $1.1 million (Q1 2026), $582533.0 (Q4 2025), and $945945.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Oric Pharmaceuticals | 1.44 Bn | 1.44 Bn | - | 1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.12 Mn |
| Jun 30, 2026 | 1.12 Mn |
| Mar 31, 2026 | 1.09 Mn |
| Mar 31, 2026 | 1.09 Mn |
| Dec 31, 2025 | 582,533.00 |
| Dec 31, 2025 | 582,533.00 |
| Sep 30, 2025 | 945,945.00 |
| Sep 30, 2025 | 945,945.00 |
| Jun 30, 2025 | 923,573.00 |
| Jun 30, 2025 | 923,573.00 |
| Mar 31, 2025 | 920,060.00 |
| Mar 31, 2025 | 920,060.00 |
| Dec 31, 2024 | 462,507.00 |
| Dec 31, 2024 | 462,507.00 |
| Sep 30, 2024 | 726,035.00 |
| Sep 30, 2024 | 726,035.00 |
| Jun 30, 2024 | 698,910.00 |
| Jun 30, 2024 | 698,910.00 |
| Mar 31, 2024 | 695,246.00 |
| Mar 31, 2024 | 695,246.00 |